Nice article, but investors seem to have a problem adding 1+1 and having it equal $$$$$$$$$. Maybe they will wake up when the word gets out. As we all know anything can happen when good or bad news hits the streets.
I currently think that anything to the price it is right now would be crazy not to buy. I bought yesterday at 2.33-2.40 range with all the spare cash I had. The chance of Marqibo approval was not priced into Tekmira. Almost everybody had written it off and/or forgot about Tekmiras technology being used in it. Marqibo's 7-4 recommendation is only good for TKMR. It also gives investors who are bullish about Marqibo to get some action without any of the risk associated with share dilution that TLON will need to do.
Dan, thanks for a very informative article. Are you a patent lawyer and/or do you have a science background? Your apparent understanding of the scientific issues and of the patent law seems prescient. It is unusual to find such deep, intelligent analysis on this free, public venue. Very interesting; thanks again. Please keep writing. I have a sizable vested interest in a solution where TKMR is rewarded for their contributions. Too bad ALNY chooses to fight rather than collaborate.
I'm new here.. I just bought in this morning on the recommendation from someone on another board and your amazing article. I check lots of stock recommendations, but this one caught me.
As I was reading it, I thought to myself that this was the BEST review or a product that I have ever read in over 10 years of trading and investing. Kudos to you.. I wish everyone that gets published on Seeking Alpha wrote like you!
I coincidentally came across this article published this morning regarding anti-NGF studies. I am not familiar with all of this, but it seems to relate. Will this March 12th advisory review effect TKMR?
Thanks! It's nice to see people in here. Ill know when it's time to sell when this board is full of spammers. Haha...right now it seems we are not even worth their time. I am convinced all that Tkmr needs is a little press. As i have learned with other early biotech, press can start to build momentum very quickly and sometimes for no reason related to the advancement of the science. It's frustrating to see great news go unnoticed as well.
Can you link the article? I have not seen it yet.
As I mentioned in the SA article, investor villages message board is great and full of some smart people.